UMR MD2 P2COE, Université de la Méditerranée, Faculté de Médecine, Marseille, France.
Hum Immunol. 2010 Nov;71(11):1073-6. doi: 10.1016/j.humimm.2010.08.010. Epub 2010 Aug 21.
Immunocompetent cells express various G-protein-coupled receptors that transduce extracellular signals across the plasma membrane. Among them, CXCR4 and CCR5 chemokines receptors and adenosine A(2A) receptors (A(2A)R) are involved in inflammatory processes. Considering that A(2A)R activation may have incidence on CXCR4 and CCR5 protein expression through heterologous desensitization process, we tested Adonis, an agonist-like monoclonal antibody to A(2A)R on CD4+ CEM T-cells. We found that Adonis inhibited the CEM cell growth, upregulated A(2A)R and downregulated CXCR4 and CCR5 without modifying the CD4 expression. By reducing the expression of CXCR4 and CCR5 chemokines receptors utilized as entry co-receptors by HIV-1 during viral infection of CD4 expressing cells, Adonis stimulation of A(2A)R appears as a valuable means to treat infected cells.
免疫活性细胞表达各种 G 蛋白偶联受体,这些受体将细胞外信号转导穿过质膜。其中,CXCR4 和 CCR5 趋化因子受体和腺苷 A(2A)受体(A(2A)R)参与炎症过程。鉴于 A(2A)R 的激活可能通过异源脱敏过程对 CXCR4 和 CCR5 蛋白表达产生影响,我们测试了 Adonis,一种针对 CD4+CEM T 细胞上的 A(2A)R 的激动剂样单克隆抗体。我们发现 Adonis 抑制了 CEM 细胞的生长,上调了 A(2A)R,下调了 CXCR4 和 CCR5,而不改变 CD4 的表达。通过减少 HIV-1 在感染表达 CD4 的细胞时作为进入共受体的 CXCR4 和 CCR5 趋化因子受体的表达,A(2A)R 的 Adonis 刺激似乎是治疗感染细胞的一种有价值的手段。